학술논문

Folliculin inactivation and cutaneous leiomyosarcoma in Birt-Hogg-Dubé syndrome.
Document Type
Article
Source
British Journal of Dermatology. Apr2023, Vol. 188 Issue 4, p571-572. 2p.
Subject
*LEIOMYOSARCOMA
*ESTRONE
*SYNDROMES
*TUMOR suppressor genes
*SARCOMA
*KIDNEY tumors
Language
ISSN
0007-0963
Abstract
Https://doi.org/10.1093/bjd/ljac138 Dear Editor, Cutaneous leiomyosarcoma (cLMS) is a rare soft tissue sarcoma where the genetic drivers implicated in carcinogenesis are not completely characterized despite extensive genomic profiling.[1] The presentation of cLMS in Birt-Hogg-Dubé (BHD) syndrome, which is caused by heterozygous pathogenic variants in the folliculin ( I FLCN i ) gene,[2] adds to our mechanistic understanding of the pathogenesis of cLMS and implicates I FLCN i loss. Primary cutaneous leiomyosarcoma arising in a patient with Li-Fraumeni syndrome: a neoplasm with unusual histopathologic features and loss of heterozygosity at TP53 gene. Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. [Extracted from the article]